000 | 01968 a2200529 4500 | ||
---|---|---|---|
005 | 20250517013819.0 | ||
264 | 0 | _c20151202 | |
008 | 201512s 0 0 eng d | ||
022 | _a1872-7549 | ||
024 | 7 |
_a10.1016/j.bbr.2015.01.028 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGou, Hongyan | |
245 | 0 | 0 |
_aProtective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice. _h[electronic resource] |
260 |
_bBehavioural brain research _cApr 2015 |
||
300 |
_a87-96 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAmphetamine-Related Disorders _xdrug therapy |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBody Temperature _xdrug effects |
650 | 0 | 4 |
_aCholecystokinin _xpharmacology |
650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
650 | 0 | 4 |
_aDopamine Agents _xtoxicity |
650 | 0 | 4 |
_aDopamine Plasma Membrane Transport Proteins _xmetabolism |
650 | 0 | 4 |
_aDopaminergic Neurons _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethamphetamine _xtoxicity |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aNeurodegenerative Diseases _xchemically induced |
650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 |
_aStereotyped Behavior _xdrug effects |
650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
700 | 1 | _aWen, Di | |
700 | 1 | _aMa, Chunling | |
700 | 1 | _aLi, Ming | |
700 | 1 | _aLi, Yingmin | |
700 | 1 | _aZhang, Wenfang | |
700 | 1 | _aLiu, Li | |
700 | 1 | _aCong, Bin | |
773 | 0 |
_tBehavioural brain research _gvol. 283 _gp. 87-96 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbr.2015.01.028 _zAvailable from publisher's website |
999 |
_c24573652 _d24573652 |